There is still a need for more research but recent research showed that over a 17-month period, more than half of the participants lost 5% of their initial body weight (10 pounds for a 200 pound person) and about a fifth of the participants lost 10% of their starting body weight (20 pounds for a 200 pound person)
This article explains how semaglutide, tirzepatide, and retatrutide compare, why receptor activity matters, why clinical trial results should be interpreted carefully, and why physician-supervised treatment is essential for safe, sustainable results
That may feel manageable for a few hours, but it often worsens jitters, reflux, nausea, or an underfed feeling later in the day
This contributes to national pharmacovigilance and helps the MHRA identify emerging safety signals from unregulated products